Protects against clinical disease associated with SIV.
Protects against clinical disease caused by SIV subtypes H1N1 and H3N2.
Significantly reduced lung lesions in challenge studies.
Produces excellent HI titers response for both H1N1 and H3N2 subtypes.
Serologically superior to autogenous vaccines.
Safe, tested in thousands of pigs (99.5% reaction free).
No reactions in pregnant sows, even given a double dose (4ml) at five and two weeks prefarrowing.
Formulated with the dual emulsion adjuvant, Microsol Diluvac Forte to optimize the immune response and high serological titers.
For use in healthy swine as an aid in the prevention of influenza caused by serotype A swine influenza (sub-types H1N1 and H3N2). This product contains an inactivated US midwest field isolate of subytpe H3N2 and an inactivated subtype H1N1 of swine influenza type A virus in Microsol Diluvac Forte adjuvant.
Shake well, aseptically inject intramuscularly. Administer a 2.0 mL dose at 3 weeks of age or older, followed by one 2.0 mL dose 3 weeks later.
Please contact us for discount pricing on large orders.
Call toll free 1-800-892-6978
or email us at email@example.com